189 related articles for article (PubMed ID: 10699325)
1. Distribution of immunoglobulin G (IgG) and A (IgA) subclasses following Q fever vaccination with soluble phase I Coxiella burnetii extract.
Camacho MT; Outschoorn I; Kovácová E; Téllez A
Vaccine; 2000 Mar; 18(17):1773-7. PubMed ID: 10699325
[TBL] [Abstract][Full Text] [Related]
2. Distribution of IgA subclass response to Coxiella burnetii in patients with acute and chronic Q fever.
Camacho MT; Outschoorn I; Echevarría C; Kovácová E; Yebra M; Maté I; Auffray P; Téllez A
Clin Immunol Immunopathol; 1998 Jul; 88(1):80-3. PubMed ID: 9683553
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
[TBL] [Abstract][Full Text] [Related]
4. Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever.
Capo C; Iorgulescu I; Mutillod M; Mege JL; Raoult D
Clin Diagn Lab Immunol; 1998 Nov; 5(6):814-6. PubMed ID: 9801340
[TBL] [Abstract][Full Text] [Related]
5. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.
Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M
J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626
[TBL] [Abstract][Full Text] [Related]
6. Role of immunoglobulin G subclasses in Q fever.
Camacho MT; Outschoorn I; Tellez A
Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1070-5. PubMed ID: 8681982
[TBL] [Abstract][Full Text] [Related]
7. Long-Term immune responses to Coxiella burnetii after vaccination.
Kersh GJ; Fitzpatrick KA; Self JS; Biggerstaff BJ; Massung RF
Clin Vaccine Immunol; 2013 Feb; 20(2):129-33. PubMed ID: 23192629
[TBL] [Abstract][Full Text] [Related]
8. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of various serological techniques for diagnosing Coxiella burnetii infection.
Slabá K; Skultéty L; Toman R
Acta Virol; 2005; 49(2):123-7. PubMed ID: 16047740
[TBL] [Abstract][Full Text] [Related]
10. Persistent high antibody titres against Coxiella burnetii after acute Q fever not explained by continued exposure to the source of infection: a case-control study.
Jajou R; Wielders CC; Leclercq M; van Leuken J; Shamelian S; Renders N; van der Hoek W; Schneeberger P
BMC Infect Dis; 2014 Nov; 14():629. PubMed ID: 25421141
[TBL] [Abstract][Full Text] [Related]
11. [Q fever with endocarditis: clinical presentation and serologic follow-up of 21 patients].
Duroux-Vouilloz C; Praz G; Francioli P; Péter O
Schweiz Med Wochenschr; 1998 Apr; 128(14):521-7. PubMed ID: 9592893
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Q fever using indirect microimmunofluorescence.
Imbert G; La Scola B
Methods Mol Biol; 2006; 345():197-202. PubMed ID: 16957357
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
[TBL] [Abstract][Full Text] [Related]
14. Components of protective immunity.
Zhang G; Zhang Y; Samuel JE
Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
[TBL] [Abstract][Full Text] [Related]
15. Predominant immunoglobulin A response to phase II antigen of Coxiella burnetii in acute Q fever.
Fournier PE; Raoult D
Clin Diagn Lab Immunol; 1999 Mar; 6(2):173-7. PubMed ID: 10066649
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR
Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569
[TBL] [Abstract][Full Text] [Related]
17. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
Shannon JG; Heinzen RA
Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
Deringer JR; Chen C; Samuel JE; Brown WC
Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
[TBL] [Abstract][Full Text] [Related]
19. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
PLoS One; 2015; 10(4):e0124664. PubMed ID: 25909586
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.
Ledbetter L; Cherla R; Chambers C; Zhang Y; Zhang G
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
